Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Return on Assets (2022 - 2026)

Axsome Therapeutics' Return on Assets history spans 5 years, with the latest figure at 0.0% for Q1 2026.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Assets hit 0.0% in Q1 2026 for Axsome Therapeutics, roughly flat from 0.0% in the prior quarter.
  • Over the last five years, Return on Assets for AXSM hit a ceiling of 0.0% in Q1 2026 and a floor of 0.01% in Q2 2024.
  • Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2023.
  • The widest YoY moves for Return on Assets: up 0bps in 2023, down 0bps in 2023.
  • Tracing AXSM's Return on Assets over 5 years: stood at 0.01% in 2022, then grew by 28bps to 0.0% in 2023, then fell by -26bps to 0.01% in 2024, then skyrocketed by 47bps to 0.0% in 2025, then increased by 0bps to 0.0% in 2026.
  • Business Quant data shows Return on Assets for AXSM at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.